INTRODUCTION
AMPA receptors (AMPA-Rs) and kainate receptors (KA-Rs) are members of the ionotropic glutamate receptor (iGluR) family, functioning as ligand-gated ion channels that mediate excitatory synaptic transmission and plasticity in the brain (Traynelis et al., 2010) . Their functions are regulated by the composition of channel-forming core subunits, association with auxiliary proteins, phosphorylation, receptor trafficking, and interaction with cytoplasmic scaffolds (Jackson and Nicoll, 2011; Kim and Sheng, 2004; Shepherd and Huganir, 2007) . Defining molecules that mediate receptor modulation is critical in understanding basic brain function and disease mechanisms. The molecular composition of AMPA-Rs and KA-Rs is diverse, and the complete landscape is currently unclear.
The iGluR's channel core is a tetrameric assembly of receptor subunits, GluA1-4 for AMPA-Rs and GluK1-5 for KA-Rs (Collingridge et al., 2009) . Auxiliary transmembrane subunits bind to core iGluR subunits. They are found across species (Wang et al., 2008) and include stargazin/transmembrane AMPA-R regulatory proteins (stg/TARPs) (Chen et al., 2000; Tomita et al., 2003) , SOL-1 (Zheng et al., 2004) , cornichon2/3 (CNIH-2/3) (Schwenk et al., 2009 ), synDIG1 (Kalashnikova et al., 2010 , and CKAMP44 (von Engelhardt et al., 2010) for AMPA-Rs and Neto1/2 (Zhang et al., 2009) for KA-Rs. The combinatorial effect of various auxiliary subunits binding to channel-forming core subunits extends the architectural and functional complexity of iGluRs in the brain (Farrant and CullCandy, 2010; Jackson and Nicoll, 2011) .
iGluR complexes are extensively studied, yet new binding proteins are continuously reported. Biochemical hurdles in handling intact membrane proteins have been overcome for AMPA-Rs and KA-Rs by robust purification protocols (Nakagawa et al., 2005; Zhang et al., 2009 ). In combination with liquid chromatographic separations in line with tandem mass spectrometers, peptide analysis can identify nearly all proteins present in a low-complexity sample (Savas et al., 2011) .
In this study, we wished to identify iGluR interactors that are less abundant or difficult to find. Specifically, we compared the interactomes of native AMPA-Rs and KA-Rs and identified an AMPA-R auxiliary subunit, GSG1L. GSG1L modifies AMPA-R channel function very differently from the known auxiliary modulators, revealing another functional repertoire of AMPA-Rs. This study provides a proof-of-principal for identifying novel interactors of iGluRs with the use of our interactome data. Our results may also reveal previously unexpected molecular and functional diversity of iGluR complexes.
RESULTS

Identification of Candidate Proteins that Copurify with AMPA-Rs and KA-Rs in Rat Brain
We performed immunoaffinity purification of native AMPA-Rs and KA-Rs followed by shotgun liquid chromatography-tandem mass spectrometry (LC-MS/MS) protein analysis (AP-MS/MS). The copurifying proteins were directly analyzed by multidimensional protein identification technology (MudPIT) (Washburn et al., 2001 ). As a negative control, we performed a parallel purification with normal rabbit IgG. Any protein binding to IgG was excluded from analysis.
A summary and complete list of the proteins that copurify with brain AMPA-Rs and KA-Rs are shown in Tables 1 and S1 , respectively. Our purification was highly enriched for the target proteins containing the epitopes of the antibodies used for affinity purification, as demonstrated by numerous spectrum counts (s.c.) and peptide counts (p.c.) for GluA2 (2526 s.c., 193 p.c.) and GluK2 (790 s.c., 88 p.c.) . Nearly all known AMPA-R interacting membrane proteins, such as TARPs (stg/g-2, g-3, g-4, g-5, g-7, and g-8), CNIH-2/3, and CKAMP44, were identified in our AMPA-R preparation. Although we did not find synDIG1 itself, we identified homologs (Tables 1 and S1 ). Among the known auxiliary subunits, stg/TARPs were most abundantly detected, whereas fewer s.c.'s and p.c's were observed for the others. Furthermore, the known KA-R auxiliary subunits Neto1 and Neto2 were detected with KA-Rs (Tables 1  and S1 ). These results indicate that our purification was robust, and therefore, further investigation of the list may identify other interactors. Our results extend the current knowledge of the interactomes of AMPA-Rs and KA-Rs.
Predicted Protein GSG1L Is Expressed the Brain and Binds to AMPA-Rs Among the candidates, we focused on the predicted protein GSG1L, a membrane protein specifically copurifying with AMPA-Rs ( Figure 1A ). It is a distant homolog of stg/TARPs belonging to the extended claudin family ( Figure 1B ). Furthermore, its peptide counts were comparable to known AMPA-R auxiliary subunits ( Figure 1A and Table 1 ). GSG1L was reproducibly identified from rat brain (Tables 1 and S1 ) and also copurified with AMPA-Rs from human cortex (Figures S1A-S1C), indicative of evolutionary conservation of the interactome. Collectively, this evidence provided support for further investigation.
While it is in the claudin family, GSG1L is distinct from stg/ TARPs, as there is a large evolutionary distance between GSG1L and stg/TARPs. The nearest family member of GSG1L is the product of germline-specific gene 1 (GSG1), whose transcript is specifically expressed in the germline and whose function is unknown (Tanaka et al., 1994) .
Similar to claudins, the predicted topology of GSG1L has a cytoplasmic N terminus, four transmembrane segments, two extracellular loops, and a cytoplasmic C terminus ( Figure 1C ). Loop1 is $50% longer in GSG1L than in TARPs. The extracellular and cytoplasmic domains of GSG1L are not conserved with stg/ TARPs ( Figure S1D ). These regions are responsible for modulating AMPA-R function in stg/TARPs (Tomita et al., 2005) ; therefore, GSG1L may potentially have a unique modulatory function.
GSG1L was annotated as a predicted protein in the rat genome. Its protein existence was unknown and two alternatively spliced transcripts were predicted (GenBank entries XP_002725730.1 and XP_574558.2; predicted molecular weights 26 and 36 kDa, respectively). The shorter variant lacks the first 102 amino acids, including the first transmembrane domain. We first created three polyclonal antibodies against different epitopes of the predicted GSG1L protein ( Figure S1D ). The first epitope, Lp1, is present only in the product of the longer spliced variant. When we purified native AMPA-Rs from rat brain tissue and examined GSG1L by Western blot, all three antibodies detected a band at the molecular weight of 43 kDa, consistent with the long isoform ( Figures 1D1 and 1D2 ). These results establish that GSG1L is a protein expressed in rat brain and copurifies with native AMPA-Rs.
GSG1L Interacts Specifically with AMPA-R Subunits In Vitro
To reconstitute the interaction in nonneuronal cells, we transfected a plasmid encoding hemagglutinin (HA)-tagged GSG1L into stable human embryonic kidney (HEK) cell lines that express either GluA2 or GluK2 and immunoprecipitated the HA-GSG1L by using an anti-HA antibody. GluA2 coimmunoprecipitated with GSG1L, whereas GluK2 did not ( Figures 1E1 and 1E2 ). Under the same conditions, the known KA-R auxiliary subunit Neto2 specifically interacted with GluK2 but not with GluA2. Conversely, the specific interaction of GSG1L with GluA2 and not with GluK2 was also observed when the immunoprecipitation was performed with the use of antibodies directed against each glutamate receptor subunit ( Figures S2A1 and 2) . Furthermore, GSG1L and GluA2 partially colocalize near the plasma membrane when coexpressed in a stable HEK cell line with the use of a DOX-inducible expression system ( Figure 1F ). Similar results were obtained when the two proteins were coexpressed through transient transfection ( Figure S2B ). GluA1 also forms a complex with GSG1L, as determined by coimmunoprecipitation experiments ( Figure 1G ). These observations establish the physical interaction between GSG1L and AMPA-R subunits.
Functional Interaction of GSG1L with AMPA-Rs Next, we investigated functional interactions between GSG1L and AMPA-Rs. Transfection of GSG1L into a stable HEK cell line that expresses GluA2 increased the surface expression of GluA2 as compared to transfecting EGFP. In fact, GSG1L increased the surface expression of GluA2 as efficiently as stg (Figures 2A and 2B) , indicating that surface expression of AMPA-Rs is positively modulated by GSG1L.
A functional interaction was also detected by a cell-death assay (Sans et al., 2003; Shanks et al., 2010) (Figure S3 ). For this purpose, we created stable TetON HEK cell lines that express GluA2 in a DOX-dependent fashion and constitutively express GSG1L or stg ( Figure S3A ). Cell death was observed after GluA2 expression was induced by DOX in the cell line constitutively expressing stg or GSG1L. Cytotoxicity was blocked by the AMPA-R antagonist NBQX and was not detected in the absence of stg or GSG1L ( Figure S3C ). Glutamate in the media thus triggered the cell death by activating AMPA-Rs whose function was enhanced by stg or GSG1L.
GSG1L Profoundly Slows AMPA-R Recovery from the Desensitized State TARPs, which are distantly related to GSG1L (Figures 1B and 1C) , alter AMPA-R gating kinetics (Tomita et al., 2005) . Specifically, deactivation and desensitization rates are slowed by both type I and type II TARPs (with the exception of g-5; Jackson and Nicoll, 2011) , and recovery from desensitization is accelerated (Priel et al., 2005) . To examine GSG1L's potential function, we coexpressed it with GluA2-Q (flip) in HEK 293T cells. Channel kinetics were assessed by ultrafast agonist application to outside-out membrane patches. In response to a sustained L-glutamate pulse (10 mM for 100 ms), the GSG1L AMPA-R complex desensitized approximately 2-fold more slowly (data were fitted with two exponentials; weighted t des = 4.76 ± 0.16 ms, n = 27, versus 9.50 ± 0.21 ms, n = 10; p < 0.0001; t test) (Figures 2C and 2D [left bar graph] ). This difference is largely due to an increase in the relative amplitude of the slow component of the decay (A slow = 10 ± 2% and 47 ± 5% without and with GSG1L, respectively) and, to a lesser extent, to an increase in the time constants of the individual components (t fast and t slow shift from 4.09 ± 0.13 ms and 11.58 ± 0.85 ms to 4.86 ± 0.40 ms and 15.18 ± 0.82 ms, respectively). In addition, the 20%-80% rise time of these responses was also slightly slower with GSG1L (0.23 ± 0.02 ms versus 0.19 ± 0.01 ms; p < 0.05; t test).
A more dramatic effect surfaced when recovery from desensitization was analyzed via a two-pulse protocol. Whereas GluA2 recovered with a time constant of 18 ± 1 ms (n = 10), the presence of GSG1L slowed recovery by $10-fold (t rec = 196 ± 28 ms, n = 6; p < 0.005, Mann-Whitney U test) (Figures 2D [right Known primary interactors and candidate interactors are listed by common name and IPI number. The spectrum count (Spec), peptide count (Pep), and coverage percentage (%AA) identified by LC-MS/MS as well as the normalized (Norm) abundance of the protein relative to the immunoprecipitated target protein are listed for proteins in both the GluA2 (A2) and GluK2 (K2) preparations. The current annotated rat protein database does not provide complete representation of the proteins in the rat genome. Thus, to identify Shisa-6, Shisa-9, and Neto1 (shown in italics), we searched against a concatenated database consisting of the human-mouse-rat protein databases. References of known and candidate interactors are provided in the Extended Discussion. Black dots represent proteins that were also found in a smaller-scale duplication experiment.
(See Table S1 for full lists.) (G) HEK cells were transfected with plasmids expressing the proteins indicated at the top of each lane. FLAG tagged GluA1 and 2 subunits were affinity purified using FLAG beads. The bound protein was eluted using FLAG epitope peptide. Western blots were conducted using the indicated antibodies. mVenus variant of EYFP was used as a negative control.
(See Figures S1 and S2 as well.)
bar graph] and 2E). Interestingly, despite the structural similarity between GSG1L and TARPs (Figures 1C and S1D) , this recovery phenotype is in fact opposite of what has been described for TARPs acting on GluA1 but parallels the effect of CKAMP44, a structurally unrelated Cys-knot protein (von Engelhardt et al., 2010) . However, GSG1L and CKAMP44 have opposite effects on modulation of desensitization. Therefore, GSG1L is an auxiliary factor that confers newly identified gating properties, further increasing the AMPA-R functional repertoire. Collectively, these data establish the existence of a functional interaction between GSG1L and AMPA-Rs.
Localization of GSG1L in Neurons
The in situ hybridization data in the Allen Brain Atlas indicate GSG1L RNA signals in the hippocampus, striatum, and cortex (Lein et al., 2007) . Consistently, GSG1L immunoreactivity was detected in CA3 pyramidal neurons and partially colocalized with excitatory synaptic marker PSD-95 ( Figure 3A ). Despite our efforts, none of the antibodies generated could detect endogenous GSG1L in dissociated cultured cortical or hippocampal neurons. However, our antibodies could detect GSG1L when it was moderately overexpressed in cultured neurons. We speculate that our antibodies do not have affinity high enough to detect the endogenous proteins in cultured neurons and/or that the expression level of GSG1L in culture is lower than that in brain tissue.
To gain insight into the distribution of GSG1L in neurons, we analyzed the subcellular localization of GSG1L transfected into cortical neurons. To detect GSG1L at the neuronal cell surface, we used a GSG1L construct with an HA epitope tag in the extracellular loop1 (see Experimental Procedures). Consistent with the physical and functional interactions described above, surface GSG1L colocalized with endogenous AMPA-R subunits GluA1 and GluA2 ( Figures 3B and 3C ). The punctate subcellular distribution of surface GSG1L also colocalized with the excitatory synaptic marker PSD-95 ( Figure 3D ). These results suggest that GSG1L exists at the excitatory synapses in neurons where AMPA-Rs are present.
DISCUSSION Interactome Data Identify Candidates Forming the iGluR Complex
By searching through the data set for membrane proteins that specifically copurify with AMPA-Rs and homologs of known interactors, we reduced the list of candidates significantly. After taking into account the s.c.'s and p.c.'s, we thought it likely that GSG1L is a biologically significant AMPA-R interactor ( Figure 1A) . Validation of the interaction is the rate-limiting step, requiring multiple experimental approaches. Additional investigations of other candidates from our data are expected to validate additional components of AMPA-R and KA-R complexes (see Extended Discussion).
GSG1L Is an AMPA-R-Specific Auxiliary Subunit
The GSG1L gene is implicated as playing roles in the nervous system. Its transcript level increases during synapse formation (C) Example current responses of outside-out patches from HEK293T cells expressing GluA2-Q(flip) without (black) or with (red) GSG1L to a 100 ms application of 10 mM L-Glu (holding potential À60 mV). Data were fitted with two exponentials. The weighted t des of the traces presented here is 5.55 ms and 10.70 ms in the absence and presence of GSG1L, respectively. (D) Summary bar graph for the time constants of desensitization (left) and recovery from desensitization (right). Data are presented as mean ± SEM. ****p < 0.0001 (t test); **p < 0.005 (Mann-Whitney U test). (E) Representative current traces of outside-out patches from HEK293T cells expressing GluA2-Q(flip) demonstrating recovery from desensitization in the presence (red) or absence (black) of GSG1L. The paired-pulse protocol consisted of a 100 ms pulse of 10 mM L-Glu followed by a 10 ms pulse in an interval increasing by 10 ms (only selected sweeps are shown). Traces are peak-scaled to the amplitude of the first pulse. Dashed lines indicate the single-exponential fits of the recovery (t rec = 15 ms and 140 ms for GluA2-Q(flip) without and with GSG1L, respectively; summarized in D). (See Figure S3 as well.) (Brusé s, 2010; Lai et al., 2011) and decreases in Huntington's disease (Becanovic et al., 2010) .
Both GSG1L and TARPs are members of the tetraspanin superfamily, with GSG1L belonging to the evolutionarily distant claudin family. The extracellular loop1 of GSG1L is least conserved (19% homology and 6.25% identity) when compared with stg/TARPs and is substantially longer ($50%) ( Figures 1C and S1D ). Because this loop is essential for ion channel modulation by stg/TARPs (Menuz et al., 2008; Tomita et al., 2005) , divergence in AMPA-R channel modulation may be due to mechanistic differences in how the loop interacts with AMPA-Rs. Indeed, whereas TARPs speed recovery from the desensitized state, GSG1L slows this parameter, mimicking the structurally unrelated Cys-knot protein CKAMP44 (von Engelhardt et al., 2010) . Given that desensitization and recovery from the desensitized state have an impact on high-frequency transmission (Arai and Lynch, 1998) , synaptic AMPA-Rs associated with GSG1L are not expected to follow high-frequency trains with great fidelity. Additional experiments are necessary to define the mechanisms of binding and functional modulation between GSG1L and TARPs with AMPA-Rs.
Although stg/TARPs increase surface expression of AMPA-Rs in HEK cells, there was no change in the amplitude of the AMPA-R mediated current in neurons overexpressing stg (Kessels et al., 2009) . Increased surface expression of AMPA-Rs by GSG1L in HEK cells may not warrant such modulation occurring in neurons. Additional experiments are needed to investigate the differences and similarities between GSG1L and stg/TARPs in the modulation of synaptic physiology.
GSG1L is structurally related to stg/TARPs yet confers completely different function to AMPA-Rs; therefore, investigating homologs of known interactors may reveal more about the functional repertoire of AMPA-Rs. In fact, we identified many related proteins of known interactors (Tables 1 and S1 ). For example, the LRRC and Shisa families of proteins are related to known AMPA-R interactors LRRTM2 and CKAMP44 (de Wit et al., 2009; Pei and Grishin, 2012) . Similarly, PRRT 1 (NG5 and synDIG4), and pancortin-3 (Olfm1) are shown to copurify with AMPA-Rs (von Engelhardt et al., 2010) . Our study extends the interactome by identifying homologs such as PRRT 2 and Olfm3.
Given the large number of auxiliary subunits identified for AMPA-Rs, questions regarding their distribution in the brain and their stoichiometry remain. Different auxiliary subunits simultaneously interact with a single tetramer of GluA subunits (Kato et al., 2010) . AMPA-R complexes with different molecular composition may be used during spatiotemporal regulation in specific neurons and synapses. Exactly how this extensive diversity contributes to the activity of neural circuits and behavior remains unclear and is an important question that still needs to be addressed.
EXPERIMENTAL PROCEDURES
Purification of AMPA and KA-Rs from Brain Purification of AMPA-Rs and KA-Rs from rat brain was performed according to previous protocols used for single-particle EM study of native AMPA-Rs (Nakagawa et al., 2005) . All experiments involving animal tissues were performed according to procedures approved by the Institutional Animal Care and Use Committee at UCSD.
Mass Spectrometry
Tryptic digests of resuspended TCA precipitates were subjected to Multidimensional Protein Identification Technology (MudPIT) (Washburn et al., 2001 ). Low-resolution LTQ mass spectrometers were utilized for rat samples, and high-resolution LTQ Orbitrap Velos were used for human samples. The. RAW and parameter files will be publicly available at http://fields.scripps. edu/published/iGluR upon publication.
Plasmid DNA Construction Rat GSG1L cDNA was synthesized (Genscript) on the basis of GenBank entry XP_574558.2 and tagged with HA or FLAG. The expression plasmids pTREt, pIRESmcherry (Clontech), and pBOSS (Shanks et al., 2010) were used.
Coimmunoprecipitation Experiments HEK cells were transfected with various expression plasmids, and the cellular lysates were prepared from detergent extracts. Anti-HA, -FLAG, -GluA2CT, and -GluK2CT antibodies were used for immunoprecipitation.
Generation of Stable TetON HEK Cell Lines
Cell lines were generated with the use of previously described methods (Farina et al., 2011; Shanks et al., 2010) .
Surface Labeling of GluA2 in HEK Cells
TetON HEK cells (Clontech) were transfected with appropriate pTREt plasmids in order to coexpress GluA2 together with GSG1L, stg, or EGFP. Surface GluA2 was live labeled with an anti-GluA2-NTD antibody (1:100, Chemicon MAB397).
Neuron Transfection and Surface Labeling
Embryonic day 18 cortical culture and surface labeling were performed as previously described (Shanks et al., 2010; Sala et al., 2003) with slight modifications.
Electrophysiology
Voltage-clamp recordings were performed on outside-out patches from HEK 293T cells as described previously (Rossmann et al., 2011) .
Immunohistochemistry A 6-week-old rat (male) was anesthetized and fixed by perfusion with the use of 4% paraformaldehyde in normal rat Ringer solution; 40 mm cryostat brain sections were used. 
Supplemental Information EXTENDED DISCUSSION
Relating Known Interactors to Their References TARPs, CNIHs, CKAMP44, Netos are reviewed in (Jackson and Nicoll, 2011) PSD-95, PSD-93, SAP97, SAP-102, GRIPs are reviewed in (Kim and Sheng, 2004) Protein 4.1 (Shen et al., 2000) AP-2, NSF (Lee et al., 2002) Kelch (Salinas et al., 2006) Relating Candidate Interactors to Their References MAGUK p55, CASK, Lin7 are major synaptic scaffold proteins and are justifiable as potential indirect interactors (Kim and Sheng, 2004) . Liprin interacts with AMPA-Rs via GRIP (Wyszynski et al., 2002) and is an indirect interactor. NGL-3 (LRRC4b) binds directly to PSD-95 (Woo et al., 2009) . Because PSD-95 binds to stg/TARPs (Bats et al., 2007; Schnell et al., 2002) , which binds directly to GluA2, NGL-3 is a candidate indirect interactor.
Leucine-rich transmembrane protein, LRRTM2 interacts with AMPA-Rs (de Wit et al., 2009 ) and is part of a large protein family. It is then plausible that members of the LRRTM family identified in our interactomes would be prime candidates for further experimental verification. Those include proteins listed as LRRC family in Table 1. FLRT-2 and Latrophilin functionally interact with AMPA-Rs (O'Sullivan et al., 2012) . Neurexin (Nrxn) and neuroligin (Nlgn) form a complex and interact with PSD-95 (Irie et al., 1997) , while PSD-95 interacts with stargazin/TARPs (Bats et al., 2007; Schnell et al., 2002) .
Eph receptors and their ligands ephrins functionally intersect with AMPA-Rs in synapses (Ethell et al., 2001 ) and were detected with AMPA-Rs.
MyosinXVIII was the most abundantly found protein in the GluK2 interactome and thus was included in Table 1 as a candidate. DHHC5 interacts with GRIP (Thomas et al., 2012) , which interacts with GluA2 (Dong et al., 1997) , and thus it is considered as an indirect interactor.
RTRT family is related to LAR which binds to liprin (Dunah et al., 2005) . LAR is also a receptor for NGL-3 (Woo et al., 2009) , which is described above.
Shisa-6 belongs to the Shisa family (Pei and Grishin, 2012 ) that includes the well established AMPA-R binding partner CKAMP44 (von Engelhardt et al., 2010) .
Pentraxins are described as AMPA-R binding proteins in the literature (O'Brien et al., 1999; Sia et al., 2007) . Interestingly we find these proteins associating preferentially with kainate receptors.
SynDIG1 is a known interactor of AMPA-Rs and belongs to the PRRT family of proteins. PRRT 1 (NG5 and synDIG4), and pancortin-3 (Olfm1) are known to co-purify with AMPA-Rs in the supplementary figure of (von Engelhardt et al., 2010) . Our study extends the interactome by identifying their homologs such as PRRT 2 and Olfm3 (Table1).
Candidates for Future Discovery
Many proteins that were previously reported to play roles in neurological and psychiatric disorders and synaptic plasticity were found in our interactome. For example, in Table S1 , IL1RAPL1 known as X-linked interleukin-1 receptor accessory protein-like 1 precursor was found together with its ligand RPTPdelta in the AMPA-R preparation (Yoshida et al., 2011) .
Fewer interacting partners are known for KA-Rs compared to AMPA-Rs. Neto1/2, MAGUK scaffolds, and Kelch interact with and modulate KA-R function (Garcia et al., 1998; Marshall et al., 2011; Zhang et al., 2009) . Consistently, these proteins were among the most abundant hits in our KA-R interctome ( Figure 1A2 and Table 1 ). The actin based motor myosin XVIII (Foth et al., 2006) was also represented abundantly in the KA-R interactome. Given the localization of KA-Rs in sophisticated actin rich spine architectures in CA3 pyramidal cells, myosin XVIII may potentially be an important candidate. Interestingly, myosin XVIII has a PDZ domain next to the motor domain. The C-termini of KA-R subunits are known PDZ ligands and thus it will be interesting to test if interactions exist between the PDZ domains of myosin XVIII and KA-Rs.
The secreted pentraxins are known interactors of AMPA-Rs (O'Brien et al., 1999; Sia et al., 2007) . However, our results indicate that they are more abundantly found with KA-Rs, indicating the possibility of pentraxin function in modulating KA-R function. We also find significant peptide counts for neuronal secreted protein Olfm specifically found with AMPA-Rs.
EXTENDED EXPERIMENTAL PROCEDURES Antibodies
Anti-GluA2CT antibody and ProteinA sepharose beads conjugated with this antibody were described previously (Nakagawa et al., 2005) . Anti-GluK2CT antibody was affinity purified from rabbit serum obtained from rabbits that were immunized with the following peptide antigen, CVKTEEVINMHTFNDRRLPGKEMTA. CNBr-activated Sepharose beads (GE Healthcare) were conjugated with a GST fusion protein that contains the antigen sequence, and used for affinity purification column. Normal rabbit IgG was purchased from Pierce. The purified antibody was covalently conjugated with ProteinA Sepharose using DMP (Pierce).
The Lp1, Ct1, and Ct2, peptide antigens for anti-GSG1L antibodies were, RFHTGIWYSCEEELGGPGEKC, CRSSAHEAAEL NRQCWVLGHWV, and CKVFEQGYREEPTFIDPEAIKYFR respectively, and were synthesized. Each antigen was conjugated to maleimide activated KLH via cysteine and used to immunize rabbits (Genscript). The antibodies were affinity purified using columns conjugated via CNBr, purified GST fusion proteins expressed in bacteria. The amino acid sequences of GSG1L fused to GST using pGEX4T-1 plasmid were GST-Lp1: TYWCQGTQRVPKPGCGQGGGANCPNSGANATANSTAAPVAASPAGAPYSWEAGDERFQLR RFHTGIWYSCEEELGGPGEKCRSFIDLAPASEK, GST-Ct3: GDSWPRSSAHEAAELNRQCWVLGHWV, and GST-Ct8: TKTVIEFRHKR KVFEQGYREEPTFIDPEAIKYFRERIEKGDVSEEED, respectively. The antigens are underlined.
Purification of AMPA and KA-Rs from Rat Brain Using Protein A Sepharose beads covalently conjugated with antibodies that specifically recognize GluA2 andGluK2, we purified native AMPA-R and KA-R complexes from CHAPS extracted brain membranes obtained from P15 rats that were anesthetized with isofluorane and decapitated. Protocols approved by IACUC of UCSD were followed. Beads conjugated with normal rabbit IgG were prepared similarly and used during purification as negative control. The adopted purification protocol was similar to what was used for purifying native AMPA-R complexes for EM studies (Nakagawa et al., 2005) . Rat brains were homogenized in 20 mM HEPES, pH 7.4, 320 mM sucrose, 5 mM EDTA, 5 mM EGTA, 30 mM NBQX supplemented with protease inhibitors (1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupetin, 1 mg/ml pepstatin, and 500 mM benzamidine). Supernatant was obtained by centrifuging the homogenate at 3,000 g for 15 min and then, further spun at 38,400 g for 15 min to obtain a membrane pellet (P2 fraction). P2 was resuspended in SB1 (20 mM HEPES, pH 7.4, 1 M KI, 5 mM EDTA, 5 mM EGTA, and 30 mM NBQX) and membranes were collected by centrifugation. Membranes were further washed with WB (20 mM HEPES, pH 7.4, 5 mM EDTA, 5 mM EGTA, 30 mM NBQX) to remove KI. Finally, membranes were solublized in RB (20 mM HEPES, pH 7.4, 100 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% CHAPS, 30 mM NBQX, with protease inhibitors) for 3hr with gentle stirring at 4 C and ultracentrifuged at 100,000 g to remove insoluble material. The final supernatant was applied to appropriate antibody affinity column (0.25 ml bed volume, antibody concentration 2 mg/ml). After washing the column with 3 ml of sample buffer, bound proteins were eluted with 100 mM glycine pH 2.5, 1% CHAPS and each eluted fractions were immediately mixed with 1/10 volume of 1M TrisHCl pH8.5. The affinity purified material was then precipitated with 15% TCA (trichloroacetic acid). The experiment was duplicated using smaller number of rat brains (at approximately 1/2 scale). The duplicate results are summarized in the Compare_ALL tab. For experiments shown in Figure 1D , the column elution was conducted using 20 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM EDTA, 5 mM EGTA, 1% CHAPS, 30 mM NBQX, 0.5 mg/ml GluA2 C-terminal epitope peptide (GYNVYGIESVKI).
Purification of AMPA-R from Human Brain Human brain (cortex) was obtained through the National Disease Research Interchange (NDRI), Researcher: Yates (code YAJ2), TSRI: IRB-11-5719. The antigen of the antibody against GluA2 is conserved in rat and human. GluA2 from human cortex was immunoaffinity purified using identical purification protocol used to purify rat GluA2.
Mass Spectrometry
Sample Preparation. TCA precipitate was resuspended in 8M urea. Next the extracts were processed with ProteasMAX (Promega, Madison, WI, USA) per the manufacturer's instruction. The samples were subsequently reduced by 20 min incubation with 5mM TCEP (tris(2 carboxyethyl)phosphine) at room temperature and alkylated in the dark by treatment with 10mM Iodoacetamide for 20 additional minutes. The proteins were digested over-night at 37 degrees with Sequencing Grade Modified Trypsin (Promega, Madison, WI, USA) and the reaction was stopped by acidification.
Multidimensional Protein Identification Technology (MudPIT) and LTQ and LTQ Orbitrap Mass Spectromtery. The protein digest was pressure-loaded onto a 250-mm i.d capillary packed with 2.5cm of 10-mm Jupiter C18 resin (Phenomenex, Torrance, CA, USA) followed by an additional 2.5cm of 5-mm Partisphere strong cation exchanger (Whatman, Clifton, NJ). The column was washed with buffer containing 95% water, 5% acetonitrile, and 0.1% formic acid. After washing, a 100-mm i.d capillary with a 5-mm pulled tip packed with 15 cm 4-mm Jupiter C18 resin (Phenomenex, Torrance, CA, USA) was attached to the filter union and the entire splitcolumn (desalting column-filter union-analytical column) was placed inline with an Agilent 1100 quaternary HPLC (Palo Alto, CA) and analyzed using a modified 5-step separation described previously (Washburn et al., 2001) . The buffer solutions used were 5% acetonitrile/0.1% formic acid (buffer A), 80% acetonitrile/0.1% formic acid (buffer B), and 500 mM ammonium acetate/5% acetonitrile/0.1% formic acid (buffer C).
Step 1 consisted of a 75 min gradient from 0%-100% buffer B. Steps 2-5 had a similar profile except 3 min of 100% buffer A, 5 min of X% buffer C, a 10 min gradient from 0%-15% buffer B, and a 105 min gradient from 10%-55% buffer B (except for step 5 which %B was increased from 10% to 100%). The 5 min buffer C percentages (X) were 10, 40, 60, 100% respectively for the 5-step analysis. As peptides eluted from the microcapillary column, they were electrosprayed directly into an LTQ mass spectrometer (ThermoFinnigan, Palo Alto, CA).
For LTQ analysis (Rat GluA2, GluK2 and normal IgG): As peptides eluted from the microcapillary column, they were electrosprayed directly into an LTQ 2-dimensional ion trap mass spectrometer (ThermoFinnigan, Palo Alto, CA) with the application of a distal 2.4 kV spray voltage. A cycle of one full-scan mass spectrum (400-1400 m/z) followed by 7 data-dependent MS/MS spectra at a 35% normalized collision energy was repeated continuously throughout each step of the multidimensional separation. Application of mass spectrometer scan functions and HPLC solvent gradients were controlled by the Xcalibur datasystem.
For LTQ velos Orbitrap analysis (Human GluA2): A seven step MudPIT was employed (10, 30, 50, 70, 90, 100% buffer C) . A cycle of one full-scan mass spectrum (400-1800 m/z) at a resolution of 60,000 followed by 20 data dependent MS/MS spectra at a 35% normalized collision energy was repeated continuously throughout each step of the multidimensional separation. Maximum ion accumulation times were set to 500ms for survey MS scans and to 100ms for MS2 scans. Charge state rejection was set to omit singly charged ion species and ions for which a charge state could not be determined for MS/MS. Minimal signal for fragmentation was set to 1000. Dynamic exclusion was enabled with a repeat count:1, duration:20.00S, list size:300, exclusion duration 30.00S, exclusion mass with high/low: 1.5 m/z. Application of mass spectrometer scan functions and HPLC solvent gradients were controlled by the Xcaliber data system.
Analysis of Tandem Mass Spectra
Protein identification and quantification analysis were done with Integrated Proteomics Pipeline (IP2, Integrated Proteomics Applications, Inc. San Diego, CA) using ProLuCID, DTASelect2 and Census. Tandem mass spectra were extracted into ms1 and ms2 files (McDonald et al., 2004) from raw files using RawExtract 1.9.9 (http://fields.scripps.edu/downloads.php) and were searched against IPI rat protein database (For Rat searches:version 3.0, released on 06-28-2007; For Shisa, SynDIG1, and Neto1 identifications from Rat purifications: concatenated human-mouse-rat version 3.71, released_03-24-2010; For Human GluR searches version 3.57, released 01-01-2009)) plus sequences of known contaminants such as keratin and porcine trypsin concatenated to a decoy database in which the sequence for each entry in the original database was reversed (Peng et al., 2003) using ProLuCID/Sequest (Eng J, 1994) . LTQ data was searched with 3000.0 milli-amu precursor tolerance, for LTQ velos Orbitrap data we used 50.0ppm tolerance for precursor ions and the fragment ions for both searches were restricted to a 600.0ppm tolerance.
All searches were parallelized (Sadygov et al., 2002) and performed on The Scripps Research Institute's garibaldi 64-bit LINUX cluster with 2848 cores. Search space included all fully-and half-tryptic peptide candidates with no missed cleavages restrictions. Carbamidomethylation (+57.02146) of cysteine was considered as a static modification, we require 2 peptides per protein and at least one trypitic terminus for each peptide identification. The ProLuCID search results were assembled and filtered using the DTASelect program (version 2.0) (Cociorva et al., 2007; Tabb et al., 2002) with false discovery rate (FDR) of 0.05, under such filtering conditions, the estimated false discovery rate was below 1% at the protein level in all analysis.
The RAW files and parameter files will be publically available at http://fields.scripps.edu/published/iGluR upon publication.
Plasmid DNA Construction Rat GSG1L cDNA was synthesized (Genscript) based on GenBank entry XP_574558.2. An HA tag in the N-terminus (ntHA) or C terminus (ctHA) was introduced using PCR. These fragments were subcloned between EcoRI and SalI sites of pTREt vector (Clontech). To generate pBOSS-GSG1LctHA-IRES-mCherry, EcoRI-SalI fragment was first cloned into pIRES-mCherry vector (Clontech), then the EcoRI-NotI fragment containing GSG1L was subcloned into modified pBOSS vector (Shanks et al., 2010) . pBOSS vector drives the expression of a gene of interest using an elongation factor promoter. For the surface labeling experiments, a GSG1L construct was created that has an HA tag in the extracellualr loop1 (AAPVAA*SPAGAPY, where HA tag was inserted at the asterisk). All DNA fragments created by PCR were sequence verified.
Co-immunoprecipitation of GSG1L-HA Proteins with iGluRs in HEK Cells
Co-immunoprecipitation of iGluRs with GSG1L (see Figures 1D1 and 2) . TetON HEK cells (Clontech) were used to create stable cell lines. TetON-GluA2flipFLAG#4 (a stable TetON HEK cell line that DOX dependently express GluA2flip-FLAG) and TetON-GluK2#16 cells (a stable HEK cell line that DOX dependently expresses GluK2-FLAG) were transfected with pTREt-GSG1LctHA, pTREtB-HANeto2 or pTREtB-EGFP constructs using calcium phosphate methods and grown for 12 hr with 30mM NBQX and 1mM kynurenic acid. Protein expression was then induced with 7.5mg/ml DOX and 1mM sodium butyrate. After 24 hr cells were washed with cold D-PBS twice and resuspended in 900ul of buffer containing 50mM Na-HEPES, 85mM NaCl, 15mM KCl and protease inhibitors (1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupetin, 1 mg/ml pepstatin, and 500 mM benzamidine). Membranes were lysed with 0.25% DDM (Anatrace, SOL-grade) in the above buffer for 1.5 hr at 4 C, ultracentrifuged at 35 krpm (Beckman, TLA-55) for 15 min at 4 C. The supernatant was incubated with HA antibody (HA.11 Covance) for about 15 hr. 30 ml of protein A sepharose beads were incubated for 3 hr. After washing the beads 3 times in buffer, protein was eluted off the beads by boiling with SDS-PAGE loading buffer containing 100 mM DTT. Western blotting was done using anti-GluA2CT, anti-GluK2CT and anti-HA antibody (HA.11, Covance).
Co-immunoprecipitation of GSG1L with iGluR Subunits (see Figures 1E1 and 2) . TetON HEK cells were used instead of receptor stable cell lines. The following combinations were transfected: pTREt-GluA2flipFLAG/pTREt-GSG1LctHA, pTREt-GluA2flipFLAG/ pTREtBa-EGFP, pTREt-GluK2/pTREt-GSG1LctHA, pTREt-GluK2/pTREtBa-EGFP and 2 plates of pTREtBa-EGFP/pTREtGSG1LctHA. Immunoprecipications were conducted as above except anti-GluA2CT or anti-GluK2CT were used as IP antibodies.
Co-immunoprecipitation of GSG1L with GluA1 Subunit (see Figure 1G ). TetON HEK cells were used. The following plasmids were transfected: pTREt-GSG1LctHA, pTREt-Venus-HA, pTREt-GluA1-FLAG, and pTREt-GluA2flipFLAG. The FLAG tag is located at the very C-terminus of GluA1 and 2.
Surface Labeling of GluA2 in HEK Cells
TetON HEK cells (Clontech) were plated on poly-L-lysine coated glass coverslips. Two days later, cells were co-transfected with pTREt-GluA2flop-FLAG and one of pTREt-GSG1LctHA, pTREt-GSG1LntHA, pTREtBa-EGFP or pTREt-Stargazin and cultured in the presence of 1mM kynurenic acid and 30mM NBQX to block the cell toxicity. The next day, transgenes were induced by the application of 7.5mg/ml DOX and 1mM sodium butyrate. Sodium butyrate is used to relax the chromatin structure and enhance protein expression of the protein of interest from DOX inducible promoter. 24 hr later, surface GluA2 were live labeled using antiGluA2-NTD antibody (1:100, Chemicon MAB397) for 15 min in 5% CO 2 incubator at 37 C. After washing, cells were fixed with 4% formaldehyde in 0.1M phosphate buffer (pH7.4) for 7min. Goat anti-mouse IgG conjugated with Alexa568 (Invitrogen, Molecular Probes) was used to visualize the labeled GluA2. Images of each condition were recorded using a CCD camera (Hamamatsu photonics, ORCA) mounted on an epifluorescent microscope (Olympus, 10x objective lens) using the identical settings throughout the experiment.
Generation of Stable TetON HEK Cell Line that DOX Dependently Expresses GluA2 and Constitutively Expresses GSG1L
To generate the cell line, we took the same approach as previously described (Shanks et al., 2010 ), but we co-transfected pBOSSGSG1LntHA-IRES mCherry with Zeocin resistance gene encoding plasmid (pCMVZeo, Invitrogen) into TetON-GluA2flipFLAG#4 cell line.
Generation of Stable TetON HEK Cell Line that DOX Dependently Expresses GluA2 and GSG1L
GSG1LntHA and GluA2-FLAG were subcloned into dual expression plasmid modified from pTREt (Clontech) described previously (Farina et al., 2011) . This plasmid was co-transfected with hygromycin resistance gene encoding plasmid into TetON HEK cell (Clontech).
Cell Death Assay Using Stable Cell Lines
Stable cell lines, TetON-GluA2flipFLAG#4, TetON-GluA2flipFLAG-pBOSS-stargazin-IRESmCherry#7, TetON-GluA2flipFLAG-pBOSS-GSG1LntHA-IRESmCherry#25 were replated in the culture media without NBQX at sparse density in 3 wells. Two days after the plating, 2 wells were induced with 7.5 mg/ml DOX and 1mM sodium butyrate, one of them was supplemented with 30mM NBQX and 1 well was left as control without drug (no-drug). Approximately 0, 24, 48 and 72 hr after the induction, DIC images of cells were taken.
Time Course Experiment
TetON-GluA2flipFLAG#4, TetON-GluA2flipFLAG-pBOSS-GSG1LntHA-IRESmCherry#25 cells were plated on 6 well plates at the density of 1.5x10^6 cells / well. The next day, 4 wells of cells were induced with 7.5mg/ml DOX and 1mM sodium butyrate. 6, 12, 18 and 24 hr later, 1 well of each line was washed using 1ml PBS once, harvested in 1ml PBS, spin down at 4 C, supernatant removed, and flash frozen in liquid N 2 . At 24 hr time point, non-induced cells were also harvested. Frozen pellets were resuspended in 400ml of PBS and 200 ml of 4xDTT SDS-PAGE sample buffer was added. Western blotting was done with GluA2CT and anti-HA antibody (Covance).
Neuron Transfection and Surface Labeling
Embryonic day 18 cortical culture and surface labeling were conducted as previously described (Shanks et al., 2010; Sala et al., 2003) with slight modifications. Briefly, the cortex without the hippocampus was dissected and culture media was supplemented with 1.5% FCS. 16DIV cortical neurons were transfected with pTREt-GSG1L-surface HA tag and pTetON-Advanced plasmids (at a 9:1 ratio) using calcium phosphate methods. At 18 DIV, cells were induced with 5mg/ml DOX for 24$48 hr. Cells were labeled using anti-HA monoclonal antibody (1:1000, Covance) or anti-HA polyclonal (1:50, Santa Cruz) followed by rabbit GluA2CT (1:200), antiGluA1CT (1:50) (Nakagawa et al., 2005) or anti-PSD-95 monoclonal antibody (1:200, clone K28/43) with secondary antibodies: anti-rabbit IgG conjugated with Alexa488 or anti-mouse IgG conjugated with Alexa568 (1:200, Clontech). Images were recorded using CCD camera (Hamamatsu photonics, ORCA) mounted on a spinning disk confocal fluorescent microscope (Olympus, 60x objective lens).
Electrophysiology
Voltage clamp recordings were performed on outside-out patches from HEK293T cells as described previously (Rossmann et al., 2011) . Briefly, cells were transfected with GluA2-Q (flip) and GSG1L plasmids (DNA ratio 1:2) or GluA2-Q (flip) alone. Current responses of outside-out patches (voltage-clamped at À60 mV) were elicited by fast application of 10 mM L-glutamate via a Q-tube and recorded using Axopatch-1D amplifier, Digidata1322 interface and pClamp 9.2 software (Molecular Devices). The rate of receptor desensitization was measured by fitting the current decay during a 100 ms application of L-glutamate with a double-exponential function. Recovery from desensitization was assessed using a two-pulse protocol where a 100 ms agonist application is followed by a 10 ms application in increasing intervals. The relative peaks of the response to the second pulse were then plotted against time elapsed from the first pulse and fitted with a single-exponential function. ± values are SEM. A) Cartoon depicting the DOX inducible expression of GluA2 and constitutive expression of stargazin (stg) or GSG1L. Specifically, these cells constitutively express (stg or GSG1L)-IRES-mCherry module under the control of constitutive elongation factor promoter, and a reverse Tet transcriptional element (rTet). The latter enhances transcription of the GluA2flip-FLAG transgene from the minimal CMV promoter when the drug doxycycline (DOX) is present in the cell media. Sodium butyrate was also added together with DOX to enhance protein induction. (B) Western blot showing the time course of GluA2 expression after DOX induction in the indicated stable cell lines. Top: TetON GluA2flipFLAG#4 cell line that DOX dependently expresses GluA2. Bottom: TetON GluA2flipFLAG pBOSS-GSG1LntHA#25 cell line that DOX dependently expresses GluA2 and constitutively expresses HA tagged GSG1L. Membranes were probed with antibodies indicated at the bottom. We also observed that GSG1L accelerates glycosylation of GluA2 ( Figure S3B ). This effect was not observed in the case of stargazin (Shanks et al., 2010) and is specific to GSG1L. (C) The trajectory of the cytotoxicity after inducing GluA2 expression is shown by the DIC images of the cells taken on different days in TetON GluA2flipFLAG pBOSS-stg-IRES-mCherry#7 (C1), TetON GluA2flipFLAG pBOSS-IRES-GSG1LntHA#25 (C2), and TetON GluA2flipFLAG (C3) cell lines. The cells on the left column were untreated (No drugs), whereas the other columns were treated with DOX+sodium butyrate (NaButyrate) with (+NBQX) or without 30 mM NBQX. Scale bar = 200 mm. Insets are representative enlarged views. The time course of cell death however was slower when GSG1L was present instead of stargazin (complete cell death in 2 days for stargazin versus 3 days for GSG1L), indicating possible differences between stargazin and GSG1L in modulating AMPA-R function.
